'For
the quarter ending March 2024, consolidated Net sales (including other operating income) of Britannia Industries has increased 1.15% to Rs 4069.36 crore compared to quarter ended March 2023. Operating profit margin has declined from 19.91% to 19.35%, leading to 1.68% decline in operating profit to Rs 787.45 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 50.33% to 50.44%. Purchase of finished goods cost rose from 4.72% to 4.74%. Employee cost decreased from 4.24% to 3.98%. Other expenses rose from 20.79% to 21.53%. Other income rose 1.72% to Rs 57.34 crore. PBIDT fell 1.45% to Rs 844.79 crore. Provision for interest fell 24.15% to Rs 26.44 crore. Loan funds declined from Rs 2,997.37 crore as of 31 March 2023 to Rs 2,064.96 crore as of 31 March 2024. Inventories declined from Rs 1,193.26 crore as of 31 March 2023 to...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Nov-2024)
Gland Pharma
-
-
NII growth improves to 4% in Q2FY25
-
Revenue up 6.9% YoY to Rs 1064.0 cr, PAT up 4.5% YoY to Rs 307.9cr in Q2FY2025
|
|